Incident-event rate of preventable drug-related morbidity in older adults in Nova Scotia

Canadian Journal of Geriatrics

Volumn 9, Issue 5, 2006, Pages 159-163

  MacKinnon, Neil J ^a   Hartnell, Nicole R ^a   Bowles, Susan K ^b   Kirkland, Susan A ^b   Jones, Erika J M ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Medication use; Prescribing; Preventable drug related morbidity

Indexed keywords

AMBULATORY CARE; ARTICLE; CANADA; DATA BASE; DRUG INDUCED DISEASE; DRUG USE; EMERGENCY WARD; HOSPITAL ADMISSION; INCIDENCE; LABORATORY TEST; MORBIDITY; OUTCOME ASSESSMENT; PRESCRIPTION;

EID: 33846893169     PISSN: 17181879     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Baker GR, Norton PG, Flintoft V, et al. The Canadian Adverse Events Study: the incidence of adverse events among hospital patients in Canada. CMAJ 2004;170:1678-86.
2. Nickerson A, MacKinnon NJ, Roberts N, et al. Drug-therapy problems, inconsistencies and omissions identified during a medication reconciliation and seamless care service. Healthcare Quarterly 2005;8:65-72.
3. MacKinnon NJ. Improving the management of medication use in older adults. Geriatr Today J Can Geriatr Soc 2002;5:63-5.
4. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990;47:533-43.
5. Hepler CD. Understanding adverse drug therapy outcomes. In: Hepler CD, Segal R, eds. Preventing Medication Errors and Improving Drug Therapy Outcomes. Boca Raton, FL: CRC Press; 29-71; 2003.
6. Hepler CD, Grainger-Rousseau TJ. Pharmaceutical care versus traditional treatment: is there a difference? Drugs 1995;49:1-10.
7. MacKinnon NJ, Hepler CD. Preventable drug-related morbidity in older adults: indicator development. J Managed Care Pharm 2002;8:365-71.
8. Faris RJ. Explicit Definitions to Identify Preventable Drug-Related Morbidity in an Elderly Population and Their Use as an Indicator of Quality in the Medication Use System [dissertation]. Gainesville, FL: University of Florida; 2001.
9. Morris CJ, Cantrill JA. Preventing drug-related morbidity - the development of quality indicators. J Clin Pharm Ther 2003;28:295-305.
10. Robertson HA, MacKinnon NJ. Development of a list of consensus-approved clinical indicators of preventable drug-related morbidity in older adults. Clin Ther 2002;24:1595-604.
11. MacKinnon NJ, Hepler CD. Indicators of preventable drug related morbidity in older adults: use within a managed care organization. J Managed Care Pharm 2003;9:134-41.
12. Morris CJ, Rodgers S, Hammersley VS, et al. Indicators for preventable drug-related morbidity: application in primary care. Qual Saf Health Care 2004;13:181-5.
13. Morris CJ, Cantrill JA. Preventable drug-related morbidity indicators in the US and UK. J Managed Care Pharm 2002;8:372-7.
14. Winterstein AG, Sauer BC, Hepler CD, et al. Preventable drug-related hospital admissions. Ann Pharmacother 2002;36:1238-48.
15. Easton-Carter KL, Chapman CB, Brian JE. Issues in the interpretation and design of studies investigating drug-related morbidity and mortality. J Pharm Pract Res 2002;32:235-9.
16. Morris CJ, Cantrill JA, Bate JR. How the use of preventable drug-related morbidity indicators can improve medicines management in primary care. The Pharmaceutical Journal 2003;271:682-6.
17. Hepler CD. A promising way forward to the goal of systematic medicines management. The Pharmaceutical Journal 2003;271:674.
18. Flanagan PS, MacKinnon NJ, Bowles SK, et al. Validation of four clinical indicators of preventable drug-related morbidity. Ann Pharmacother 2004;38:20-4.
19. Upshur RE, Goel V. Measuring the impact of influenza on hospital admission rates of he elderly in Ontario, a 5-year admission rate analysis, 1988-1993. Can J Public Health 2000;91:144-7.